Jiali Peng

944 total citations
21 papers, 668 citations indexed

About

Jiali Peng is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Jiali Peng has authored 21 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Immunology. Recurrent topics in Jiali Peng's work include RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers) and Immune Cell Function and Interaction (3 papers). Jiali Peng is often cited by papers focused on RNA modifications and cancer (4 papers), Cancer-related molecular mechanisms research (4 papers) and Immune Cell Function and Interaction (3 papers). Jiali Peng collaborates with scholars based in China, United States and Sweden. Jiali Peng's co-authors include Xiaohong Liang, Chunhong Ma, Lifen Gao, Xianhong Du, Chunyang Li, Yong Xu, Yufeng Cheng, Zhifeng Wang, Yuan Liu and Tixiao Wang and has published in prestigious journals such as The Journal of Immunology, Cancer Research and Oncogene.

In The Last Decade

Jiali Peng

19 papers receiving 662 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiali Peng China 11 391 290 176 74 56 21 668
Carmen M. Anadon United States 10 187 0.5× 195 0.7× 334 1.9× 141 1.9× 53 0.9× 18 634
Ivan H. Chan United States 10 393 1.0× 362 1.2× 165 0.9× 36 0.5× 12 0.2× 28 711
Isabelle Cousineau Canada 13 227 0.6× 355 1.2× 314 1.8× 82 1.1× 11 0.2× 24 776
Cathy Quemener France 10 201 0.5× 224 0.8× 371 2.1× 91 1.2× 43 0.8× 11 644
Ganga Gopinathan United Kingdom 5 104 0.3× 140 0.5× 169 1.0× 69 0.9× 27 0.5× 9 393
Maarit Ahtiainen Finland 16 150 0.4× 358 1.2× 163 0.9× 130 1.8× 33 0.6× 46 621
Harrison Cash United States 9 363 0.9× 330 1.1× 233 1.3× 55 0.7× 22 0.4× 9 693
Larry Wong United States 9 413 1.1× 246 0.8× 157 0.9× 60 0.8× 11 0.2× 10 698
Rosalie Joosten Netherlands 9 85 0.2× 261 0.9× 279 1.6× 104 1.4× 42 0.8× 13 528
Maria Pelullo Italy 12 114 0.3× 129 0.4× 332 1.9× 84 1.1× 26 0.5× 17 519

Countries citing papers authored by Jiali Peng

Since Specialization
Citations

This map shows the geographic impact of Jiali Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiali Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiali Peng more than expected).

Fields of papers citing papers by Jiali Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiali Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiali Peng. The network helps show where Jiali Peng may publish in the future.

Co-authorship network of co-authors of Jiali Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Jiali Peng. A scholar is included among the top collaborators of Jiali Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiali Peng. Jiali Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Han, Fang, Gonghua Qi, Rongrong Li, et al.. (2025). USP28 promotes PARP inhibitor resistance by enhancing SOX9-mediated DNA damage repair in ovarian cancer. Cell Death and Disease. 16(1). 305–305. 3 indexed citations
3.
Peng, Jiali, Di Zhao, Liyun Xu, et al.. (2024). Soluble Tim-3 serves as a tumor prognostic marker and therapeutic target for CD8+ T cell exhaustion and anti-PD-1 resistance. Cell Reports Medicine. 5(8). 101686–101686. 26 indexed citations
4.
Peng, Jiali, et al.. (2024). JAM3 promotes cervical cancer metastasis by activating the HIF-1α/VEGFA pathway. BMC Women s Health. 24(1). 293–293. 3 indexed citations
5.
Liang, Xuefeng, Jiali Peng, Di Sun, et al.. (2024). A retrospective cohort study on the protective effect of influenza vaccination during pregnancy in Gansu Province. Human Vaccines & Immunotherapeutics. 20(1). 2418674–2418674.
6.
Chen, Zhongshao, Jiali Peng, Cunzhong Yuan, et al.. (2023). The splicing factor SNRPB promotes ovarian cancer progression through regulating aberrant exon skipping of POLA1 and BRCA2. Oncogene. 42(31). 2386–2401. 16 indexed citations
7.
Ma, Xinyue, Chenggong Sun, Chen Zhao, et al.. (2023). Targeting TCF19 sensitizes MSI endometrial cancer to anti-PD-1 therapy by alleviating CD8+ T cell exhaustion via TRIM14-IFN-β axis. Cell Reports. 42(8). 112944–112944. 15 indexed citations
8.
Wang, Hui, et al.. (2023). The role of walnut bZIP genes in explant browning. BMC Genomics. 24(1). 377–377. 5 indexed citations
9.
Wang, Zixiang, et al.. (2022). The splicing factor SF3B4 drives proliferation and invasion in cervical cancer by regulating SPAG5. Cell Death Discovery. 8(1). 326–326. 11 indexed citations
10.
Li, Fangfang, Chen Zhao, Zixiang Wang, et al.. (2022). MEX3A promotes the malignant progression of ovarian cancer by regulating intron retention in TIMELESS. Cell Death and Disease. 13(6). 553–553. 19 indexed citations
11.
Dai, Chenyang, et al.. (2022). Acute Urinary Retention in the First-trimester of Pregnancy: A Case Report. Cureus. 1 indexed citations
12.
Peng, Jiali, et al.. (2021). Par3/integrin β1 regulates embryo adhesion via changing endometrial luminal epithelium polarity. Biology of Reproduction. 104(6). 1228–1238. 3 indexed citations
13.
Guo, Li, Yingwei Li, Chen Zhao, et al.. (2020). RECQL4, Negatively Regulated by miR-10a-5p, Facilitates Cell Proliferation and Invasion via MAFB in Ovarian Cancer. Frontiers in Oncology. 10. 524128–524128. 21 indexed citations
14.
Liu, Wen, Fuxiang Bai, Hongxing Wang, et al.. (2019). Tim-4 Inhibits NLRP3 Inflammasome via the LKB1/AMPKα Pathway in Macrophages. The Journal of Immunology. 203(4). 990–1000. 41 indexed citations
15.
Tan, Siyu, Yong Xu, Zehua Wang, et al.. (2019). Tim-3 Hampers Tumor Surveillance of Liver-Resident and Conventional NK Cells by Disrupting PI3K Signaling. Cancer Research. 80(5). 1130–1142. 117 indexed citations
16.
17.
Guo, Yinan, Hao Dong, Fuchao Ma, et al.. (2019). The clinicopathological significance of decreased miR-125b-5p in hepatocellular carcinoma: evidence based on RT-qPCR, microRNA-microarray, and microRNA-sequencing.. PubMed. 12(1). 21–39. 5 indexed citations
18.
19.
Lin, Sen, Shurong Li, Yuchen Du, et al.. (2017). TIR-Domain-Containing Adapter-Inducing Interferon-β (TRIF) Is Essential for MPTP-Induced Dopaminergic Neuroprotection via Microglial Cell M1/M2 Modulation. Frontiers in Cellular Neuroscience. 11. 35–35. 7 indexed citations
20.
Du, Yuchen, Qiang Guo, Yongmei Wu, et al.. (2016). Spatial and Temporal Distribution of Dopaminergic Neurons during Development in Zebrafish. Frontiers in Neuroanatomy. 10. 115–115. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026